SYnAbs’ mission is to generate innovative monoclonal antibodies against poor immunogenic compounds and complex antigens. Either as a custom service, or as a catalog product, IVD and Biotech players benefit from SYnAbs technologies to get access to singular binder (small molecules) and effector antibodies (transmembrane protein, GPCR, ion channels…)
SYnAbs is a CRO providing one-stop-shop solution with dedicated experienced project managers: from animal housing, immunization, antigen design and production, custom manufacturing up to several grams of purified antibodies, development of custom immunoassays, humanization for therapeutic purposes, antibody engineering…
Website
Contact
Julien Isoard, CEO
isoardj@synabs.be – +32 483 743 904
